NCT01109680View on ClinicalTrials.gov

A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Metabolism of Neramexane
Interventions
DRUG

Neramexane

Multiple dose Neramexane followed by single dose 14C Neramexane

Trial Locations (1)

2060

SGS Life Science Services, Antwerp

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT01109680 - A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | Biotech Hunter | Biotech Hunter